Due Diligence

Transactions entered into by pharmaceutical companies and medical device manufacturers require intensive preparation and competent handling. Thanks to our long-standing regulatory expertise, we are regularly involved in companies’ transactions either in our own right or as a team member in conjunction with law firms specialising in the M&A field.

Our law firm advises its clients on the regulatory assessment of pharmaceutical approvals and CE markings, including the impact of ongoing proceedings, cooperation agreements and product safety aspects (vigilance). We conduct these assessments within the framework of regulatory due diligence both nationally and internationally and can draw on a network of internationally acknowledged experts.

Our activities encompass all preparatory measures (e. g. preparation of check lists), the assessment in the data room and the creation of a final report on the findings of the regulatory assessment